跳至主要内容
临床试验/NCT05887505
NCT05887505尚未招募不适用

Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy

Taoyuan General Hospital0 个研究点目标入组 120 人开始时间: 2023年6月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
主要终点
Whether there is an association between 25(OH)D and PTH: positive or negative association , or no association

研究概览

简要总结

High concentrations of parathyroid hormone (PTH) are common in patients with hepatocellular carcinoma (HCC). This study is aimed to investigate effects of vitamin D status and its multiple mega-dosage supplementation on PTH and clinical outcomes in HCC patients before and after hepatectomy. It's a single-center, prospective, parallel, double-blind, placebo-controlled study for 120 eligible subjects. The subjects will receive consecutively 3-day intervention treatments from 7th day before surgery. 30-day postoperative mortality, postoperative complications, and laboratory data will be evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥ 20-year HCC subjects receiving laparoscopic hepatectomy
  • •2.Sign the informed consent

排除标准

  • •Using estrogen drugs, bisphosphonates, or drugs for bone disease.
  • •Consume calcium tablets within 2 weeks before operation
  • •Sarcoidosis, multiple myeloma
  • •Pregnant women or plan to become pregnant within 3 months after surgery
  • •Autoimmune hepatitis (AIH)
  • •Early liver recurrence
  • •Used to participate in other clinical trials

研究组 & 干预措施

Placebo Group

Placebo Comparator

Oral supplementation of placebo in 3 days

干预措施: Placebo (Other)

Vitamin D group

Experimental

Oral supplementation of 1,728,000 IU vitamin D3 in 3 days

干预措施: Vitamin D (Other)

结局指标

主要结局

Whether there is an association between 25(OH)D and PTH: positive or negative association , or no association

时间窗: During the study period

Ratio of liver failure

时间窗: 1 day before discharge

Ratio of liver failure

时间窗: 1 day post- OP (day 1)

Ratio of liver failure

时间窗: 7 days pre- OP (day -7)

Ratio of liver failure

时间窗: 1 day pre- OP (day -1)

次要结局

  • Complications after surgery(day 1 post-OP and 1 day before discharge)
  • 25(OH)D status(Baseline (day -7), day -1, day 1 and 1 day before discharge)
  • Prevalence of high PTH(Baseline (day -7), day -1, day 1 and 1 day before discharge)
  • Prevalence of hypomagnesemia(Baseline (day -7), day -1, day 1 and 1 day before discharge)
  • 30-day mortality(day 1 post-OP and 1 day before discharge)
  • Clinical outcomes(day 1 post-OP and 1 day before discharge)
  • Prevalence of hypercalcemia(Baseline (day -7), day -1, day 1 and 1 day before discharge)

研究者

发起方
Taoyuan General Hospital
申办方类型
Other Gov
责任方
Sponsor

相似试验